Zen-Bio

Durham, United States Founded: 1995 • Age: 31 yrs Acquired By BioIVT
Cell-based solutions are provided to accelerate therapy discovery and development.
Request Access

About Zen-Bio

Zen-Bio is a company based in Durham (United States) founded in 1995 was acquired by BioIVT in August 2024.. Zen-Bio offers products and services including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media. Zen-Bio operates in a competitive market with competitors including Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Rules-Based Medicine, among others.

  • Headquarter Durham, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Zenbio, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $251.14 K (USD), Grant

    Aug 29, 2011

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    BioIVT

    (Aug 21, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Zen-Bio

Zen-Bio offers a comprehensive portfolio of products and services, including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides human and animal blood components for research use.

Offers extracts from human tissues for scientific studies.

Delivers exosomes from stem cells for regenerative research.

Supplies ECM coated plastics for cell culture applications.

Formulates media for optimal cell growth in experiments.

Provides kits for testing compounds in metabolic diseases.

Funding Insights of Zen-Bio

  • Total Funding
  • Total Rounds 11
  • Last Round Grant — $251,144
  • First Round

    (19 May 2008)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2011 Amount Grant - Zen-Bio Valuation

investors

HHS
Oct, 2010 Amount Grant - Zen-Bio Valuation

investors

HHS
Sep, 2010 Amount Grant - Zen-Bio Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Zen-Bio

Zen-Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and BioIVT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Provider of in vitro diagnostic products and assay services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Zen-Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Zen-Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Zen-Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Zen-Bio

Zen-Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Rules-Based Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Ex-vivo human tissue studies are performed for preclinical drug discovery.
domain founded_year HQ Location
Cardiac safety testing is conducted using iPS-derived heart cells.
domain founded_year HQ Location
Ion channel screening and cardiac safety profiling services are provided.
domain founded_year HQ Location
Developer of transformational medicines for neurological disorders
domain founded_year HQ Location
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Zen-Bio

Frequently Asked Questions about Zen-Bio

When was Zen-Bio founded?

Zen-Bio was founded in 1995 and raised its 1st funding round 13 years after it was founded.

Where is Zen-Bio located?

Zen-Bio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

What does Zen-Bio do?

Founded in 1995 and based in Durham, United States, Zen-Bio operates in the biotechnology sector, focusing on metabolic diseases and cosmeceuticals. Human cell-based products, including cells, tissues, and serum from diverse donor populations and disease states such as type II diabetes and hypertension, are supplied. Contract research services, cell-based assay development, custom consultations, cell characterization, and molecular biology services are offered to support therapy development.

Who are the top competitors of Zen-Bio?

Zen-Bio's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.

What products or services does Zen-Bio offer?

Zen-Bio offers Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and 2 more products and services.

Who are Zen-Bio's investors?

Zen-Bio has 2 investors. Key investors include HHS, and BioIVT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available